<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT931-13995</title>
	</head>
	<body>
		<main>
			<p>930120 FT  20 JAN 93 / International Company News: Strong sales growth at Ares-Sorono ARES-Sorono, the Geneva-based diagnostics and pharmaceuticals group, has reported sales up 16.7 per cent to Dollars 854m from Dollars 732m for the year to December 31. The figures do not include the contribution of the OTC division, which was sold to American Home Products, the US group, during the first quarter of last year. No group profit figures were given. Pharmaceuticals sales rose 20.3 per cent to Dollars 751m from Dollars 624m. Underlying growth, excluding currencies, was 18.6 per cent. Sales in the group's three main therapeutic areas - infertility, immunology and paediatric endocrinology - all rose more than 20 per cent.</p>
		</main>
</body></html>
            